PetIQ, Inc. develops, manufactures, and distributes pet medications, and health and wellness products for dogs and cats in the United States, Canada, and Europe. It offers pet prescription medications, including products for arthritis, thyroid, and diabetes and pain treatments, as well as heartworm preventatives, antibiotics, and other specialty medications; over-the-counter medications and supplies, such as flea and tick control products in various forms comprising spot on treatments, chewables, and collars; and health and wellness products consisting of specialty treats and other pet products, which include dental treats and nutritional supplements. The company provides its products primarily under the VetIQ, PetAction Plus, Advecta, PetLock Plus, and TruProfen brands. It sells its products through distributors as well as through retail stores, including approximately 40,000 retail pharmacy locations. PetIQ, Inc. was founded in 2010 and is headquartered in Eagle, Idaho.
Industry, Sector and Symbol
Stock Exchange NASDAQ
Industry Drugs, proprietaries, & sundries
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:PETQ
CUSIPN/A
Phone208-939-8900
Debt
Debt-to-Equity Ratio0.69
Current Ratio2.35
Quick Ratio1.09
Price-To-Earnings
Trailing P/E Ratio88.49
Forward P/E Ratio44.24
P/E Growth1.4
Sales & Book Value
Annual Sales$266.69 million
Price / Sales3.17
Cash Flow$0.5188 per share
Price / Cash66.52
Book Value$4.88 per share
Price / Book7.07
Profitability
EPS (Most Recent Fiscal Year)$0.39
Net Income$-3,490,000.00
Net Margins0.17%
Return on Equity11.39%
Return on Assets6.69%
Miscellaneous
Employees225
Outstanding Shares24,530,000
Market Cap$665.34 million
PetIQ (NASDAQ:PETQ) Frequently Asked Questions
What is PetIQ's stock symbol?
PetIQ trades on the NASDAQ under the ticker symbol "PETQ."
How were PetIQ's earnings last quarter?
PetIQ Inc (NASDAQ:PETQ) announced its quarterly earnings results on Tuesday, August, 14th. The company reported $0.41 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.39 by $0.02. The company had revenue of $171.10 million for the quarter, compared to the consensus estimate of $148.48 million. PetIQ had a return on equity of 11.39% and a net margin of 0.17%. The business's quarterly revenue was up 96.2% on a year-over-year basis. View PetIQ's Earnings History.
When is PetIQ's next earnings date?
What price target have analysts set for PETQ?
2 equities research analysts have issued twelve-month price objectives for PetIQ's shares. Their predictions range from $32.00 to $40.00. On average, they expect PetIQ's stock price to reach $36.00 in the next year. This suggests a possible upside of 4.3% from the stock's current price. View Analyst Price Targets for PetIQ.
What is the consensus analysts' recommendation for PetIQ?
2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for PetIQ in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for PetIQ.
What are Wall Street analysts saying about PetIQ stock?
Here are some recent quotes from research analysts about PetIQ stock:
- 1. According to Zacks Investment Research, "PetIQ, Inc. is a pet medication and wellness company. Its product consists of Rx Medications, OTC Medications and Supplies, Health and Wellness Products. The Company serves retail stores across the mass, club, grocery, pharmacy and e-commerce channels. PetIQ, Inc. is based in Eagle, United States. " (6/6/2018)
- 2. Jefferies Financial Group Inc analysts commented, "PETQ printed a strong 1Q, incl. sales at the high end of guidance (provided 4/11) and EBITDA +4% vs. Street, amidst cautious sentiment from poor weather. FY18 guide was reiterated and encouraging commentary on 2Q should be enough despite GM % shortfall given low bar (29% short interest)." (5/16/2018)
Who are some of PetIQ's key competitors?
Who are PetIQ's key executives?
PetIQ's management team includes the folowing people:
- Mr. Mccord Christensen, Chairman of Directors & CEO (Age 46)
- Mr. John Newland, CFO & Corp. Sec. (Age 54)
When did PetIQ IPO?
(PETQ) raised $86 million in an initial public offering on Friday, July 21st 2017. The company issued 5,700,000 shares at a price of $14.00-$16.00 per share. Jefferies and William Blair served as the underwriters for the IPO and Oppenheimer, Raymond James and SunTrust Robinson Humphrey were co-managers.
Has PetIQ been receiving favorable news coverage?
News headlines about PETQ stock have trended somewhat positive this week, Accern Sentiment Analysis reports. The research group scores the sentiment of news coverage by reviewing more than twenty million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. PetIQ earned a media and rumor sentiment score of 0.11 on Accern's scale. They also assigned media stories about the company an impact score of 46.87 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company's share price in the next few days. View Recent Headlines for PetIQ.
Who are PetIQ's major shareholders?
PetIQ's stock is owned by a variety of of institutional and retail investors. Top institutional investors include Wasatch Advisors Inc. (7.93%), State of New Jersey Common Pension Fund D (3.83%), BlackRock Inc. (3.40%), Redwood Investments LLC (2.64%), Pembroke Management LTD (2.52%) and Massachusetts Financial Services Co. MA (2.35%). Company insiders that own PetIQ stock include John Newland, Mccord Christensen, Ronald Kennedy and Will Santana. View Institutional Ownership Trends for PetIQ.
Which major investors are selling PetIQ stock?
PETQ stock was sold by a variety of institutional investors in the last quarter, including Redwood Investments LLC, Fiera Capital Corp, Bank of New York Mellon Corp, Macquarie Group Ltd., Brown Advisory Inc., Bank of America Corp DE and Oppenheimer Asset Management Inc.. Company insiders that have sold PetIQ company stock in the last year include John Newland, Mccord Christensen and Will Santana. View Insider Buying and Selling for PetIQ.
Which major investors are buying PetIQ stock?
PETQ stock was bought by a variety of institutional investors in the last quarter, including Wasatch Advisors Inc., State of New Jersey Common Pension Fund D, Pembroke Management LTD, Massachusetts Financial Services Co. MA, Russell Investments Group Ltd., American Century Companies Inc., Fred Alger Management Inc. and Boston Partners. View Insider Buying and Selling for PetIQ.
How do I buy shares of PetIQ?
Shares of PETQ can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is PetIQ's stock price today?
One share of PETQ stock can currently be purchased for approximately $34.51.
How big of a company is PetIQ?
PetIQ has a market capitalization of $665.34 million and generates $266.69 million in revenue each year. The company earns $-3,490,000.00 in net income (profit) each year or $0.39 on an earnings per share basis. PetIQ employs 225 workers across the globe.
How can I contact PetIQ?
PetIQ's mailing address is 923 S. Bridgeway Pl., EAGLE ID, 83616. The company can be reached via phone at 208-939-8900 or via email at [email protected]
MarketBeat Community Rating for PetIQ (NASDAQ PETQ)
MarketBeat's community ratings are surveys of what our community members think about PetIQ and other stocks. Vote "Outperform" if you believe PETQ will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PETQ will underperform the S&P 500 over the long term. You may vote once every thirty days.
